The Patent Finder

Fovea Pharmaceuticals

Also on record
Records under this name other than the patents Fovea Pharmaceuticals holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 6 of 6 · Back to Fovea Pharmaceuticals

PatentTitleStatus Expires Confidence
US 9,107,928Compositions and Methods for Treating Ophthalmic Disorders
Formerly held
In force
 · Low confidence
In forceLow confidence
US 9,249,085Aniline Derivatives, Their Preparation and Their Therapeutic Application
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,624,159Aniline Derivatives, Their Preparation and Their Therapeutic Application
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,808,242Apparatus for Injection into an Eye
Lapsed on the fee record
Ended Aug 19, 2026 · High confidence
Lapsed on the fee recordEnded Aug 19, 2026High confidence
US 8,460,242Apparatus for intra-ocular injection
Lapsed on the fee record
Ended Jun 11, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jun 11, 2021From the USPTO record
US 8,389,530Substituted quinazoline compounds
Lapsed on the fee record
Ended Mar 5, 2017 · From the USPTO record
Lapsed on the fee recordEnded Mar 5, 2017From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited